Mechanistic studies reveal that TLR9 activation enhances expression of interleukin-1 receptor-associated kinase-M (IRAK-M), a negative feedback regulator of TLR4 signaling, attenuates TLR4-driven inflammatory cascades, ultimately ameliorating NEC severity (14). The gene discussed is TLR9; the disease is necrotizing enterocolitis.